Key result
Increased proportions of newly formed platelets are associated with an increased risk of thrombotic events and a reduced effectiveness of standard anti-platelet therapies.
Why the study?
Common intrinsic changes occurring as platelets age in the circulation are only just being explored, and understanding natural platelet ageing may identify triggers for altered platelet life span and reactivity.
This review highlights the role of platelet ageing and newly formed platelets in thrombotic risk and anti-platelet therapy effectiveness.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for reticulated platelet monitoring; prospective trials needed before clinical adoption.
Platelet ageing is an area of research which has gained much interest in recent years. Newly formed platelets, often referred to as reticulated platelets, young platelets or immature platelets, are defined as RNA-enriched and have long been thought to be hyper-reactive. This latter view is largely rooted in associations and observations in patient groups with shortened platelet half-lives who often present with increased proportions of newly formed platelets. Evidence from such groups suggests that an increased proportion of newly formed platelets is associated with an increased risk of thrombotic events and a reduced effectiveness of standard anti-platelet therapies. Whilst research has highlighted the existence of platelet subpopulations based on function, size and age within patient groups, the common intrinsic changes which occur as platelets age within the circulation are only just being explored. By understanding the changes that occur during the natural ageing processes of platelets, we may be able to identify the triggers for alterations in platelet life span and platelet reactivity. Here we review research on platelet ageing in the context of health and disease, paying particular attention to the experimental approaches taken and the robustness of conclusions that can be drawn.
No takes yet. Share an insight, caveat, or question.
Allan et al. (2022) conducted a review in Platelet ageing. Platelet ageing was evaluated. Increased proportions of newly formed platelets are associated with an increased risk of thrombotic events and a reduced effectiveness of standard anti-platelet therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: